-
- Posted Friday January 15, 2016
David Dombrowski teams with Seena Magowitz Foundation to support TGen cancer research
Boston Red Sox President of Baseball Operations named honorary chair of golf tournament supporting TGen's pancreatic cancer research
PHOENIX, Ariz. - Jan. 15, 2015 - Broadening its nationwide scope, the Seena Magowitz Golf Classic - a multi-million-dollar fundraising spectacular supporting pancreatic cancer research at theTranslational Genomics Research Institute (TGen) - will call Boston home for its 2016 event.
And the latest addition to the Boston sports scene, David Dombrowski, appointed in August as the first President of Baseball Operations for the Boston Red Sox, will serve as the event's Honorary Chair.
"I am honored to help support the Seena Magowitz Golf Classic and TGen's cutting-edge pancreatic cancer research and clinical trials," said Dombrowski, who became familiar with TGen when a family member sought treatment for cancer. "Boston is one of the truly great sports towns in America, and it's my hope that this enthusiasm and excitement will make this premier event a great success."
Dombrowski is a long-standing member of TGen's Pancreatic Cancer National Advisory Council, a group of business leaders who assist the TGen Foundation in raising funds to support research and clinical trials for pancreatic cancer. In recent years their efforts have led to a very promising new treatment regimen, shrinking greater than 80 percent of tumors in patients with advanced pancreatic cancer, and holding the promise of substantially improved patient survival.
"We are extremely pleased to have David Dombrowski as the honorary chair and about moving the Seena Magowitz Golf Classic to Boston," said Michael Bassoff, President of the TGen Foundation. "We hope to attract a whole new region of participants, as well as showcase a beautiful part of the country and all that the Boston region has to offer."
The Seena Magowitz Golf Classic has raised more than $5 million for TGen's research of pancreatic cancer, which annually claims the lives of more than 40,000 Americans, making it the nation's fourth leading cause of cancer related death.
Pancreatic cancer's lethal nature stems from its propensity to rapidly spread to other organs, especially the liver and lungs. Because no early screening test exists, the disease often goes undiagnosed until its late stages, when surgery is often no longer an option, making it difficult to treat.
TGen has also made major progress against pancreatic cancer through the work of its Stand Up to Cancer (SU2C) Pancreatic Cancer Dream Team. Importantly, as a result of TGen clinical research, the U.S. Food and Drug Administration (FDA) in 2013 approved the use of albumin-bound paclitaxel in combination with gemcitabine as a front-line therapy for patients with advanced pancreatic cancer. The Seena Magowitz Foundation helped fund the Abraxane clinical trials.
"Partnering with David Dombrowski is a dream come true for the Seena Magowitz Foundation, TGen and the hundreds of pancreatic cancer patients who need our help today," said Roger Magowitz, founder of the Seena Magowitz Foundation, named for his mother, who passed away from this aggressive disease. "Having the tournament based in Boston will provide a new opportunity to raise awareness surrounding this disease throughout New England and across the upper Atlantic seaboard."
The Seena Magowitz Foundation looks forward to announcing the date and location for the 2016 event shortly, and fully expects to take advantage of Boston's mild summertime weather. As in past years, the tournament organizers expect to garner major support from the home furnishings and bedding industry.
For more information about and Golf Classic, visit www.seenamagowitzfoundation.org. Prospective sponsors, tournament participants and dinner/concert attendees may contact: Roger Magowitz at 602-524-7636 or [email protected]; or Liz McBeth, Tournament Director, at 757-773-3622 or [email protected].
# # #
About the Seena Magowitz Foundation
The Seena Magowitz Foundation is a 501(c)(3) non-profit organization committed to advancing the awareness and eventual prevention and cure of pancreatic cancer. The Foundation is dedicated to funding top medical institutions on the leading edge of translational pancreatic cancer research committed to diagnosis, the advancement of life-extending treatment options and the ultimate goal of eradicating this deadly killer. For more information, visit: www.seenamagowitzfoundation.org.
About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit:www.tgen.org. Follow TGen onFacebook,LinkedInandTwitter @TGen.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
